CK17 Monoclonal Antibody(10A1)

Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.

The CK17 Monoclonal Antibody (10A1) is a highly specific and sensitive antibody that is designed to target and detect cytokeratin 17 (CK17) protein expression in various tissues and cells. This antibody is produced using advanced monoclonal antibody technology and is characterized by its high affinity and specificity towards CK17 protein.

The CK17 Monoclonal Antibody (10A1) is an essential tool for researchers and clinicians who are studying the role of CK17 in various diseases and conditions, including cancer, wound healing, and skin disorders. This antibody can be used for a wide range of applications, including immunohistochemistry, western blotting, and flow cytometry.

The CK17 Monoclonal Antibody (10A1) is supplied in a convenient and easy-to-use format, making it ideal for use in both research and clinical settings. This antibody is rigorously tested to ensure its quality and consistency, and it is manufactured in compliance with the highest industry standards.

Overall, the CK17 Monoclonal Antibody (10A1) is a reliable and effective tool for the detection and analysis of CK17 protein expression, and it is an essential component of any research or diagnostic program focused on this important biomarker.